![James Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Murphy
Nessuna posizione attualmente
Profilo
James B. Murphy worked as Controller at Sumitomo Pharma America, Inc. from 1990 to 1994.
From 1994 to 2001, served as Chief Financial Officer & Senior VP-Administration at HMSR, Inc. Held the position of Vice President-Finance at Whatman, Inc. between 2001 and 2003.
Worked at Oncotelic Therapeutics, Inc. from 2004 to 2012, including Vice President & Chief Financial Officer in 2011.
Served as Chief Financial Officer, Secretary & Treasurer at Morphic Medical, Inc. from 2016 to 2017.
Held the role of Chief Financial & Accounting Officer at Decibel Therapeutics, Inc. from 2022 to 2023.
Worked as Chief Financial Officer at Helix BioPharma Corp.
from 2024 to 2025.
Served as Chief Financial & Accounting Officer at Mustang Bio, Inc. in 2024.
Attended College of the Holy Cross (Massachusetts) for undergraduate studies.
Precedenti posizioni note di James Murphy
| Società | Posizione | Fine |
|---|---|---|
| HELIX BIOPHARMA CORP. | Direttore Finanziario/CFO | 02/06/2025 |
| DECIBEL THERAPEUTICS, INC. | Direttore Finanziario/CFO | 22/09/2023 |
| GI DYNAMICS, INC. | Direttore Finanziario/CFO | 01/12/2017 |
| ONCOTELIC THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/03/2012 |
Whatman, Inc.
 Whatman, Inc. Industrial MachineryProducer Manufacturing Develops, manufactures, and markets separation technology devices | Direttore Finanziario/CFO | 01/05/2003 |
Formazione di James Murphy
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
56
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Helix BioPharma Corp.
 Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
MORPHIC MEDICAL INC
 MORPHIC MEDICAL INC Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices for the treatment of diabetes and obesity, and their complexities | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HMSR, Inc.
 HMSR, Inc. Medical SpecialtiesHealth Technology Develops products for blood transfusion and collection procedures | Health Technology |
Whatman, Inc.
Whatman, Inc. Industrial MachineryProducer Manufacturing Develops, manufactures, and markets separation technology devices | Producer Manufacturing |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
